Study of ZG005 in Combination With Gecacitinib in Participants With Advanced Cervical Cancer

NCT07080216 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Cervical Cancer

Interventions

BIOLOGICAL: ZG005
DRUG: Gecacitinib
BIOLOGICAL: Bevacizumab

Sponsor

Suzhou Zelgen Biopharmaceuticals Co.,Ltd